Analyst Research

Report Title Price
Natus Medical Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
Thomson Reuters Stock Report - NATUS MEDICAL, INCORPORATION (BABY-O)
Provider: Thomson Reuters Stock Report
$25.00
Buy
Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of NATUS MEDICAL INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.
Provider: Jefferson Research
$20.00
Buy
ValuEngine Detailed Valuation Report for BABY
Provider: ValuEngine, Inc.
$127.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Natus Medical Inc Issues FY 2013 Guidance Above Analysts' Estimates; Issues Q1 2013 Mixed Guidance


Monday, 7 Jan 2013 09:00am EST 

Natus Medical Inc announced that for fiscal 2013, it expects to report revenue of $362 million to $367 million and non-GAAP earnings per share (EPS) of $0.81 to $0.84. For the first quarter of 2013, the Company expects to report revenue of $83 million to $85 million and non-GAAP earnings per share (EPS) of $0.09 to $0.10. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $347 million and EPS of $0.76 for fiscal 2013; and revenue of $82 million and EPS of $0.13 for the first quarter of 2013. 

Latest Developments for Natus Medical Inc

Latest Key Developments in Advanced

Company Quote

Natus Medical Inc
(BABY.OQ)
14.36
0.31 +2.21%
17 May 2013